Novo Nordisk Diabetes Education Program Receives NCQA Disease Management Certification in Program Design

Certification demonstrates Novo Nordisk's commitment to improving diabetes care

News provided by

Oct 23, 2014, 10:00 ET

PLAINSBORO, N.J., Oct. 23, 2014 /PRNewswire/ -- Novo Nordisk, a global leader in diabetes care, was honored with The National Committee for Quality Assurance (NCQA)'s Disease Management Certification in Program Design for its Diabetes Education Program (DEP) this month. The 2-year certification validates the DEP as a program providing quality educational support to both health care providers and patients that meets the rigorous review of the NCQA Disease Management Program Design standards. It also demonstrates the DEP's commitment to continuously enhance the quality of the program and Novo Nordisk's commitment to improve diabetes care.

NCQA Disease Management Certification standards are intended to help organizations achieve the highest level of performance possible, reduce patient risk and create an environment of continuous improvement. These standards build on NCQA's years of accreditation and certification experience, detailed market research and input from industry experts and other stakeholders. The DEP was evaluated on 68 program elements within five categories, which included evidence-based guidelines, patient services, provider programs, program marketing and operations and measurement of quality improvement efforts.

"Novo Nordisk is proud to receive the NCQA Disease Management Certification in Program Design," said Patricia Bradley, DEP Vice President, Diabetes Marketing. "The process was a rigorous evaluation of our entire DEP program and our approach to disease management. This certification underscores Novo Nordisk's commitment to provide patients and health care providers with quality resources that will help improve patient care."

"Earning NCQA Disease Management Certification indicates that a Disease Management program excels in the specific area in which it was reviewed, program design, patient outreach or disease management systems. It's an accomplishment to be proud of," said NCQA President Margaret E. O'Kane.

Part of Novo Nordisk's mission is to find ways to improve how diabetes is managed. The DEP offers comprehensive, in-office education for health care providers and support staff. The program helps teach basic to advanced diabetes management and provides educational sessions on diabetes quality measures, motivational interviewing and shared decision making. In addition, Novo Nordisk diabetes educators conduct educational classes within the community and help patients learn how to properly use a Novo Nordisk device after it has been prescribed.

About Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global health care company with more than 90 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy, and hormone therapy. Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries. For more information, visit novonordisk.us or follow us on Twitter @NovoNordiskUS.

About NCQA
NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA is committed to providing health care quality information for consumers, purchasers, health care providers and researchers.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/novo-nordisk-diabetes-education-program-receives-ncqa-disease-management-certification-in-program-design-823233982.html

SOURCE Novo Nordisk